Differential Growth Rates and <i>In Vitro</i> Drug Susceptibility to Currently Used Drugs for Multiple Isolates of Naegleria fowleri-Reference-Cited by-同舟云学术

Differential Growth Rates and In Vitro Drug Susceptibility to Currently Used Drugs for Multiple Isolates of Naegleria fowleri

Published:2022-02-23 Issue:1 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Russell A. Cassiopeia¹²,Kyle Dennis E.¹²³^ORCID

Affiliation:

1. Center for Tropical and Emerging Global Diseases, Athens, Georgia, USA

2. Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA

3. Department of Cellular Biology, University of Georgia, Athens, Georgia, USA

Abstract

Naegleria fowleri , also known as the brain-eating amoeba, is ubiquitous in warm freshwater and is an opportunistic pathogen that causes primary amoebic meningoencephalitis. Although few cases are described each year, the disease has a case fatality rate of >97%.

Funder

Georgia Research Alliance

HHS | NIH | National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01899-21

Reference60 articles.

1. Biology and pathogenesis of Naegleria fowleri

2. Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options